News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Continue Reading Previous Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories Brain Clinical Trial News Pharmaceutical Alzheon Raises $100 Million Series E Financing Round to Advance Development and Commercialization of Oral Tablet ALZ-801/Valiltramiprosate for Treatment of Alzheimer’s Disease Staff June 12, 2024 Healthcare Mental Health News Pharmaceutical Canary Speech Secures $13 Million in Series A Funding to Change How the World’s Top Healthcare Organizations Screen for Mental Wellness and Cognitive Health Staff June 12, 2024 Mental Health News Twenty Percent Of The World’s Employees Experience Loneliness While Global Employee Engagement Stagnated And Employee Wellbeing Declined Staff June 12, 2024